Table 3.
Relative contribution of HPV 16/18 or HPV6/11/16/18/31/33/45/52/58 to HPV‐associated cancers by site and by sex; World, 2012
| HPV‐related cancer site (ICD‐10 code) | Number attributable to HPVa | Relative contribution of HPV16/18b | Relative contribution of HPV6/11/16/18/31/33/45/52/58b | ||
|---|---|---|---|---|---|
| Percent | Number | Percent | Number | ||
| Cervix uteri (C53) | 530,000 | 70.8 | 370,000 | 89.5 | 470,000 |
| Anus (C21) | 35,000 | 87.0 | 30,000 | 95.9 | 33,000 |
| Vulva (C51) | 8,500 | 72.6 | 6,200 | 87.1 | 7,400 |
| Vagina (C52) | 12,000 | 63.7 | 7,400 | 85.3 | 9,900 |
| Penis (C60) | 13,000 | 70.2 | 9,100 | 84.6 | 11,000 |
| Head and neck (C01‐06, C09‐10, C32) | 38,000 | 84.9 | 32,000 | 89.7 | 34,000 |
| Total HPV‐related sites in women | 570,000 | 71.4 | 410,000 | 89.6 | 510,000 |
| Total HPV‐related sites in men | 60,000 | 82.3 | 50,000 | 90.4 | 55,000 |
| Total HPV‐related sites | 630,000 | 72.4 | 460,000 | 89.7 | 570,000 |
a
Derived from Plummer, de Martel et al.8; numbers are rounded to two significant digits.
b
Derived from Serrano et al.,14 Alemany et al.12 and Castellsague et al.13